Live
- Atkinson, Mendis, Ayub, Joseph named ICC Men’s Emerging Cricketer of the Year nominees
- Wanaparthy collector directs doctors to be available all time
- Parbhani custodial death: Prakash Ambedkar demands solatium, survey of victims of police brutality
- Indiramma illu survey should be completed in time, collector
- Excise police seize 10 litres of adulterated liquor
- AAP workers protest outside BJP leader Parvesh Verma's residence; latter distributes snacks
- I'll move the High Court, want written reply why I'm not getting Khel Ratna Award: Yogesh Kathuniya
- Malladi Venkata Krishnamurthy Lauds 'Master of Suspense Hitchcock'
- ACB hands over key documents to ED in the Formula E car race case
- How to Use Meta AI on WhatsApp for Creative Interactions
Centre approves Corbevax as precaution dose
Centre approves Corbevax as precaution dose
Highlights
The Centre on Wednesday approved Biological E's Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin, said a source.
New Delhi: The Centre on Wednesday approved Biological E's Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin, said a source.
According to the source, the Corbevax vaccine will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines.
Meanwhile, India on Wednesday reported 16,047 new Covid-19 cases in the last 24 hours.
In the same period, there were 54 additional deaths, taking the nationwide death toll to 5,26,826.
Next Story
ADVERTISEMENT
